EarningsQ3 2022 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q3 2022 Earnings Report

0 Followers

MX:ARWR Q3 2022 EPS Results

Actual EPS-$12.41

Consensus EPS-$10.39

Beat/MissMissed by -$2.03

One Year Ago EPS-$5.29

Actual Revenue$591.66M

Expected Revenue$835.20M

Beat/MissMissed by -$243.53M

YoY Revenue Growth-29.37%

QuarterQ3 2022

Date08/04/2022

TimeAfter Close

Conference CallThursday, August 4, 2022

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-28.31 / -	-2.008	―
Aug 04, 2026	2026 (Q3)	-23.31 / -24.83	-23.001	-7.94% (-1.83)
May 07, 2026	2026 (Q2)	-19.99 / -16.98	50.2	-133.82% (-67.18)
Feb 05, 2026	2026 (Q1)	0.68 / 4.02	-25.374	115.83% (+29.39)
Nov 25, 2025	2025 (Q4)	-2.04 / -2.01	-24.826	91.91% (+22.82)
Aug 07, 2025	2025 (Q3)	-17.38 / -23.00	-25.191	8.70% (+2.19)
May 12, 2025	2025 (Q2)	-3.41 / 50.20	-18.62	369.61% (+68.82)
Feb 10, 2025	2025 (Q1)	-8.69 / -25.37	-22.636	-12.10% (-2.74)
Nov 26, 2024	2024 (Q4)	-20.45 / -24.83	-18.62	-33.33% (-6.21)
Aug 08, 2024	2024 (Q3)	-9.66 / -25.19	-17.524	-43.75% (-7.67)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed